• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Macrophage migration inhibitory factor receptor CD74 expression is associated with expansion and differentiation of effector T cell

tetano

Editor, Senior Moderator
Front Immunol


. 2023 Oct 25:14:1236374.
doi: 10.3389/fimmu.2023.1236374. eCollection 2023. Macrophage migration inhibitory factor receptor CD74 expression is associated with expansion and differentiation of effector T cells in COVID-19 patients

Jaana Westmeier[SUP] 1 [/SUP], Annika Brochtrup[SUP] 1 [/SUP], Krystallenia Paniskaki[SUP] 2 3 [/SUP], Zehra Karakoese[SUP] 1 [/SUP], Tanja Werner[SUP] 1 [/SUP], Kathrin Sutter[SUP] 1 4 [/SUP], Sebastian Dolff[SUP] 2 [/SUP], Andreas Limmer[SUP] 5 6 [/SUP], Daniela Mittermüller[SUP] 1 [/SUP], Jia Liu[SUP] 4 7 [/SUP], Xin Zheng[SUP] 4 7 [/SUP], Tetiana Koval[SUP] 8 [/SUP], Igor Kaidashev[SUP] 9 [/SUP], Marc Moritz Berger[SUP] 5 [/SUP], Frank Herbstreit[SUP] 5 [/SUP], Thorsten Brenner[SUP] 5 [/SUP], Oliver Witzke[SUP] 2 [/SUP], Mirko Trilling[SUP] 1 4 [/SUP], Mengji Lu[SUP] 1 4 [/SUP], Dongliang Yang[SUP] 4 7 [/SUP], Nina Babel[SUP] 3 10 [/SUP], Timm Westhoff[SUP] 11 [/SUP], Ulf Dittmer[SUP] 1 4 [/SUP], Gennadiy Zelinskyy[SUP] 1 4 [/SUP]



Affiliations
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused millions of COVID-19 cases and deaths worldwide. Severity of pulmonary pathologies and poor prognosis were reported to be associated with the activation non-virus-specific bystander T cells. In addition, high concentrations of the macrophage migration inhibitory factor (MIF) were found in serum of COVID-19 patients. We hypothesized that these two pathogenic factors might be related and analyzed the expression of receptors for MIF on T cells in COVID-19. T cells from PBMCs of hospitalized patients with mild and severe COVID-19 were characterized. A significantly higher proportion of CD4+ and CD8+ T cells from COVID-19 patients expressed CD74 on the cell surface compared to healthy controls. To induce intracellular signaling upon MIF binding, CD74 forms complexes with CD44, CXCR2, or CXCR4. The vast majority of CD74+ T cells expressed CD44, whereas expression of CXCR2 and CXCR4 was low in controls but increased upon SARS-CoV-2 infection. Hence, T cells in COVID-19 patients express receptors that render them responsive to MIF. A detailed analysis of CD74+ T cell populations revealed that most of them had a central memory phenotype early in infection, while cells with an effector and effector memory phenotype arose later during infection. Furthermore, CD74+ T cells produced more cytotoxic molecules and proliferation markers. Our data provide new insights into the MIF receptor and co-receptor repertoire of bystander T cells in COVID-19 and uncovers a novel and potentially druggable aspect of the immunological footprint of SARS-CoV-2.

Keywords: CD4+; CD74; CD8+; COVID-19; MIF; SARS-CoV-2; cytotoxic T cells.

 
Back
Top Bottom